The Emergence of Omicron: A variant of concern - By Dr. Ashwini

Speciality: Infectious diseases


Speaker:

Dr. Ashwini M Shetty | Infedis health

Description:

A warm welcome to all the medical professionals in this interesting session on The Emergence of Omicron: A Variant of Concern - By Dr. Ashwini.

Dr. Ashwini discusses the emergence of Omicron, a variant of concern of the SARS-CoV-2 virus, which was first identified in South Africa in late 2021. Omicron quickly gained global attention due to its unprecedented number of mutations in the spike protein, raising concerns about increased transmissibility and potential resistance to existing vaccines and treatments.

Omicron's rapid spread has been attributed to its ability to evade immunity from previous infections and vaccinations more effectively than earlier variants. Dr. Ashwini highlights that, despite its higher transmissibility, preliminary data suggested that Omicron might cause less severe disease compared to the Delta variant. However, the sheer volume of cases posed significant challenges to healthcare systems worldwide, leading to increased hospitalizations and strain on medical resources.

To combat Omicron, Dr. Ashwini emphasizes the importance of booster vaccination campaigns, which have shown to enhance protection against this variant. Additionally, ongoing research and adaptation of COVID-19 treatments and preventive measures are crucial in addressing the evolving threat posed by Omicron and future variants. Public health strategies, including widespread testing, genomic surveillance, and reinforcing public health measures, remain essential in mitigating the impact of Omicron.

Therefore, get an overall knowledge of Th

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity

2.

Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.

3.

Cancer diagnosis does not spur improvements to survivors' diets or eating habits

4.

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

5.

Microplastics can cause malignant changes in lung cells


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot